Wells Fargo just delivered a contrarian gut check to Nike (NYSE:NKE | NKE Price Prediction) stock bulls, downgrading the athletic wear giant to Equal Weight from Overweight and trimming its price target to $45 from $55. The call lands with Nike stock already under pressure, down roughly 30% year to date (YTD) and off 25% over the past year.
The investor takeaway: Wells Fargo believes GLP-1 weight loss drugs are quietly rewiring consumer apparel demand. Nike, as the world’s largest footwear maker, sits on the wrong side of that shift.
| Ticker | Company | Firm | Action | Old Rating | New Rating | Old Target | New Target |
|---|---|---|---|---|---|---|---|
| NKE | Nike | Wells Fargo | Downgrade | Overweight | Equal Weight | $55 | $45 |
The Analyst’s Case
Wells Fargo’s thesis is that Nike doesn’t fit the firm’s preference for clothing outperforming athletic apparel over the next few years. The argument: GLP-1 adoption is reshaping body silhouettes and consumer wardrobes, steering wallet share toward traditional apparel and away from the “wellness through exercise” narrative that powered athletic wear for over a decade.
Layered on top are company-specific concerns. Wells Fargo cited a slower-than-expected global turnaround, international disruption likely to weigh on near-term results, and over-saturation from excess competition.
Company Snapshot
Nike is the world’s largest supplier of athletic shoes and apparel. CEO Elliott Hill is steering a “Win Now” restructuring, and the most recent quarter showed revenue of $11.28 billion (up 0.1% year over year (YoY)) with diluted EPS of $0.35 beating the $0.28 estimate.
Yet, pressure points remain visible. Net income fell 35% YoY, gross margin compressed 130 basis points to 40%, and Greater China declined 10% on a currency-neutral basis while Converse dropped 35%. Nike’s market cap stands at $52.92 billion, with shares fetching a forward P/E ratio of 22x.
Why the Move Matters Now
The downgrade crystallizes a structural concern the market hasn’t fully digested. Premium running brands like On and Hoka have eaten into Nike’s core, and the GLP-1 angle suggests the total addressable market for athletic apparel may be peaking rather than expanding.
For perspective on the sector, Lululemon (NASDAQ:LULU) stock is down roughly 36% YTD and 53% over the past year, while Victoria’s Secret (NYSE:VSCO) shares have surged 146% over the past year. That’s a striking divergence that fits Wells Fargo’s framework. For broader context on consumer rotation themes, see this analysis of GLP-1 winners and losers in 2026.
What It Means for Your Portfolio
For prudent investors, the Wells Fargo analyst downgrade reflects concerns beyond brand strength, given that Nike’s brand power remains globally unmatched. The downgrade serves as a reminder that secular consumer shifts can erode multiples even when execution stabilizes.
The bull case still rests on Hill’s turnaround eventually delivering, product innovation reigniting demand, and the 24-year streak of dividend increases rewarding patience. The bear case is exactly what Wells Fargo articulated. Investors weighing Nike stock should size positions modestly and keep an eye on China comps, gross margin recovery, and any inflection in athletic versus traditional apparel demand.